References:
1.
Brooks
JA. The Hospital-Acquired Condition Reduction Program. AJN, American
Journal of Nursing 2017;117(10):63-66.
2.
Korin
J. Cost implications of malpractice and adverse events. Hosp Formul
1993;28 Suppl 1:59-61.
3.
Baker
GR.Harvard medical practice study.
4.
Brennan
TA, Leape LL, Laird NM, et al. Incidence of adverse events and
negligence in hospitalized patients. Results of the Harvard Medical
Practice Study I. N Engl J Med 1991;324(6):370-376.
5.
Duchman
KR, Pugely AJ, Martin CT, Bedard NA, Gao Y, Callaghan JJ. Medicare’s
Hospital-Acquired Conditions Policy: A Problem of Nonpayment After Total
Joint Arthroplasty. The Journal of Arthroplasty 2016;31(9):31-36.
6.
Cromarty
J, Parikh S, Lim WK, Acharya S, Jackson TJ. Effects of hospital-acquired
conditions on length of stay for patients with diabetes. INTERN MED J
2014;44(11):1109-1116.
7.
Jackson
TJ, Michel JL, Roberts RF, Jorm CM, Wakefield JG. A classification of
hospital-acquired diagnoses for use with routine hospital data. Med J
Aust 2009;191(10):544-548.
8. Lee
GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable
infections in U.S. hospitals. N Engl J Med 2012;367(15):1428-1437.
9.
Fuller
RL, Goldfield NI, Averill RF, Hughes JS. Is the CMS Hospital-Acquired
Condition Reduction Program a Valid Measure of Hospital Performance? AM
J MED QUAL 2016;32(3):254-260.
10.
Bae S.
CMS Nonpayment Policy, Quality Improvement, and Hospital-Acquired
Conditions. J NURS CARE QUAL 2017;32(1):55-61.
11.
Wendelboe
AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G. Global public
awareness of venous thromboembolism. J THROMB HAEMOST
2015;13(8):1365-1371.
12.
Raskob
GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor
to global disease burden. SEMIN THROMB HEMOST 2014;40(7):724-735.
13.
Zhang
Z, Lei J, Shao X, et al. Trends in Hospitalization and In-Hospital
Mortality From VTE, 2007 to 2016, in China. CHEST 2019;155(2):342-353.
14.
Young
PY, Khadaroo RG. Surgical site infections. Surg Clin North Am
2014;94(6):1245-1264.
15.
Branchford
B. Clinical and financial impact of HACs: a commentary on clinical and
financial costs of hospital-acquired conditions. Translational
pediatrics 2015;4(4
):331-333.
16.
Carson
JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes
mellitus increases short-term mortality and morbidity in patients
undergoing coronary artery bypass graft surgery. J AM COLL CARDIOL
2002;40(3):418-423.
17.
Demarre
L, Van Lancker A, Van Hecke A, et al. The cost of prevention and
treatment of pressure ulcers: A systematic review. INT J NURS STUD
2015;52(11):1754-1774.
18.
Services
CFMA. Hospital-Acquired Condition Reduction Program (HACRP).
19.
Roberson
B, Reid K. HAC REDUCTION PROGRAM PENALTIES: AN UNDUE BURDEN ON ESSENTIAL
HOSPITALS. Washington, DC: Essential Hospitals Institute.
Table 1. The amount, percentage, demographic, financial and length
information of all inpatients for Hospital-Acquired Conditions in three
years.